Question 1

How does Semaglutide differ from native GLP-1?

Accepted Answer

Native GLP-1 degrades in minutes. Semaglutide features a C18 fatty acid chain that allows it to bind to albumin, extending its biological half-life to nearly a week.

Question 2

What is the primary mechanism of action?

Accepted Answer

It agonizing GLP-1 receptors to stimulate insulin release, delay gastric emptying, and alter neurological feeding behaviors.

Question 3

Is Semaglutide for human use?

Accepted Answer

No. Melbourne Peptides supplies Semaglutide exclusively for in-vitro laboratory research and analytical modeling. It is strictly not for human consumption.